306 related articles for article (PubMed ID: 34224734)
1. Opioid receptor system contributes to the acute and sustained antidepressant-like effects, but not the hyperactivity motor effects of ketamine in mice.
Zhang F; Hillhouse TM; Anderson PM; Koppenhaver PO; Kegen TN; Manicka SG; Lane JT; Pottanat E; Van Fossen M; Rice R; Porter JH
Pharmacol Biochem Behav; 2021 Sep; 208():173228. PubMed ID: 34224734
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism.
Williams NR; Heifets BD; Bentzley BS; Blasey C; Sudheimer KD; Hawkins J; Lyons DM; Schatzberg AF
Mol Psychiatry; 2019 Dec; 24(12):1779-1786. PubMed ID: 31467392
[TBL] [Abstract][Full Text] [Related]
3. Evidence for the involvement of opioid system in the antidepressant-like effect of ascorbic acid.
Moretti M; Ribeiro CM; Neis VB; Bettio LEB; Rosa PB; Rodrigues ALS
Naunyn Schmiedebergs Arch Pharmacol; 2018 Feb; 391(2):169-176. PubMed ID: 29222646
[TBL] [Abstract][Full Text] [Related]
4. Antidepressant-like effects of ascorbic acid and ketamine involve modulation of GABAA and GABAB receptors.
Rosa PB; Neis VB; Ribeiro CM; Moretti M; Rodrigues AL
Pharmacol Rep; 2016 Oct; 68(5):996-1001. PubMed ID: 27423525
[TBL] [Abstract][Full Text] [Related]
5. Creatine, similarly to ketamine, affords antidepressant-like effects in the tail suspension test via adenosine A₁ and A2A receptor activation.
Cunha MP; Pazini FL; Rosa JM; Ramos-Hryb AB; Oliveira Á; Kaster MP; Rodrigues AL
Purinergic Signal; 2015 Jun; 11(2):215-27. PubMed ID: 25702084
[TBL] [Abstract][Full Text] [Related]
6. N,N-dimethylglycine differentially modulates psychotomimetic and antidepressant-like effects of ketamine in mice.
Lin JC; Chan MH; Lee MY; Chen YC; Chen HH
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Nov; 71():7-13. PubMed ID: 27296677
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the rapid and sustained antidepressant-like effects of dextromethorphan in mice.
Saavedra JS; Garrett PI; Honeycutt SC; Peterson AM; White JW; Hillhouse TM
Pharmacol Biochem Behav; 2020 Oct; 197():173003. PubMed ID: 32755625
[TBL] [Abstract][Full Text] [Related]
8. Involvement of AMPA receptors in the antidepressant-like effects of dextromethorphan in mice.
Nguyen L; Matsumoto RR
Behav Brain Res; 2015 Dec; 295():26-34. PubMed ID: 25804358
[TBL] [Abstract][Full Text] [Related]
9. TAK-653, an AMPA receptor potentiator with minimal agonistic activity, produces an antidepressant-like effect with a favorable safety profile in rats.
Hara H; Suzuki A; Kunugi A; Tajima Y; Yamada R; Kimura H
Pharmacol Biochem Behav; 2021 Dec; 211():173289. PubMed ID: 34655652
[TBL] [Abstract][Full Text] [Related]
10. Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant.
Kokane SS; Armant RJ; Bolaños-Guzmán CA; Perrotti LI
Behav Brain Res; 2020 Apr; 384():112548. PubMed ID: 32061748
[TBL] [Abstract][Full Text] [Related]
11. Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression.
Koike H; Iijima M; Chaki S
Behav Brain Res; 2011 Oct; 224(1):107-11. PubMed ID: 21669235
[TBL] [Abstract][Full Text] [Related]
12. Ketamine: The final frontier or another depressing end?
Sial OK; Parise EM; Parise LF; Gnecco T; Bolaños-Guzmán CA
Behav Brain Res; 2020 Apr; 383():112508. PubMed ID: 32017978
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism.
Williams NR; Heifets BD; Blasey C; Sudheimer K; Pannu J; Pankow H; Hawkins J; Birnbaum J; Lyons DM; Rodriguez CI; Schatzberg AF
Am J Psychiatry; 2018 Dec; 175(12):1205-1215. PubMed ID: 30153752
[TBL] [Abstract][Full Text] [Related]
14. Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors.
Maeng S; Zarate CA; Du J; Schloesser RJ; McCammon J; Chen G; Manji HK
Biol Psychiatry; 2008 Feb; 63(4):349-52. PubMed ID: 17643398
[TBL] [Abstract][Full Text] [Related]
15. Role of BDNF/TrkB signaling in antidepressant-like effects of a group II metabotropic glutamate receptor antagonist in animal models of depression.
Koike H; Fukumoto K; Iijima M; Chaki S
Behav Brain Res; 2013 Feb; 238():48-52. PubMed ID: 23098797
[TBL] [Abstract][Full Text] [Related]
16. Mediation of the behavioral effects of ketamine and (2R,6R)-hydroxynorketamine in mice by kappa opioid receptors.
Wulf HA; Browne CA; Zarate CA; Lucki I
Psychopharmacology (Berl); 2022 Jul; 239(7):2309-2316. PubMed ID: 35459958
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms for the antidepressant-like effects of a low-dose ketamine treatment in a DFP-based rat model for Gulf War Illness.
Ribeiro ACR; Zhu J; Kronfol MM; Jahr FM; Younis RM; Hawkins E; McClay JL; Deshpande LS
Neurotoxicology; 2020 Sep; 80():52-59. PubMed ID: 32592718
[TBL] [Abstract][Full Text] [Related]
18. Lack of persistent effects of ketamine in rodent models of depression.
Popik P; Kos T; Sowa-Kućma M; Nowak G
Psychopharmacology (Berl); 2008 Jun; 198(3):421-30. PubMed ID: 18458881
[TBL] [Abstract][Full Text] [Related]
19. Effect of NMDAR antagonists in the tetrabenazine test for antidepressants: comparison with the tail suspension test.
Skolnick P; Kos T; Czekaj J; Popik P
Acta Neuropsychiatr; 2015 Aug; 27(4):228-34. PubMed ID: 25858023
[TBL] [Abstract][Full Text] [Related]
20. The novel methoxetamine analogs N-ethylnorketamine hydrochloride (NENK), 2-MeO-N-ethylketamine hydrochloride (2-MeO-NEK), and 4-MeO-N-ethylketamine hydrochloride (4-MeO-NEK) elicit rapid antidepressant effects via activation of AMPA and 5-HT
Sayson LV; Botanas CJ; Custodio RJP; Abiero A; Kim M; Lee HJ; Kim HJ; Yoo SY; Lee KW; Ryu HW; Acharya S; Kim KM; Lee YS; Cheong JH
Psychopharmacology (Berl); 2019 Jul; 236(7):2201-2210. PubMed ID: 30891619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
